🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s IDYA Holdings & Trades

First Buy
Q3 2023
Duration Held
7 Quarters
Largest Add
Q3 2025
+37,595 Shares
Current Position
13,156 Shares
$505,454 Value

Paul Tudor Jones's IDYA Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 13,156 shares of IDEAYA Biosciences, Inc. (IDYA) worth $505,454, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 7 quarters.

Based on 13F filings, Paul Tudor Jones has maintained this position in IDYA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 37,595 shares. Largest reduction occurred in Q3 2026, reducing 32,131 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's IDEAYA Biosciences (IDYA) Holding Value Over Time

Track share changes against reported price movement

Quarterly IDEAYA Biosciences (IDYA) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 -32,131 Reduce 70.95% 13,156 $38.42
Q2 2026 +2,582 Add 6.05% 45,287 $37.27
Q1 2026 -5,233 Reduce 10.92% 42,705 $33.32
Q4 2025 +10,343 Add 27.51% 47,938 $34.57
Q3 2025 +37,595 New Buy 37,595 $27.21
Q4 2023 -20,931 Sold Out 0 $0.00
Q3 2023 +20,931 New Buy 20,931 $26.98

Paul Tudor Jones's IDEAYA Biosciences Investment FAQs

Paul Tudor Jones first purchased IDEAYA Biosciences, Inc. (IDYA) in Q3 2023, acquiring 20,931 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held IDEAYA Biosciences, Inc. (IDYA) for 7 quarters since Q3 2023.

Paul Tudor Jones's largest addition to IDEAYA Biosciences, Inc. (IDYA) was in Q3 2025, adding 37,595 shares worth $1.02 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 13,156 shares of IDEAYA Biosciences, Inc. (IDYA), valued at approximately $505,454.

As of the Q3 2026 filing, IDEAYA Biosciences, Inc. (IDYA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in IDEAYA Biosciences, Inc. (IDYA) was 47,938 shares, as reported at the end of Q4 2025.